MUÑOZ RISUEÑO, Ruth,LARA CASTILLO, Mari Carmen,ETXABE ALBERDI, Amaia
申请号：
EP17382015
公开号：
EP3348266A1
申请日:
2017.01.16
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
The invention relates to a combination comprising an antineoplastic agent, e.g. an antimetabolite antineoplastic agent and a serotonin receptor (HTR) modulator, e.g. a HTR antagonist. In addition the invention relates to a pharmaceutical composition comprising a combination of the invention and a pharmaceutically acceptable excipient. The invention also relates to the combination and pharmaceutical composition according to the invention for use in medicine, particularly for use in the prevention and/or treatment of a hematological malignancy.
